The developed novel N, S-GQDs@Au-PANI nanocomposites show high sensitivity and good stability for quantitative determination of CEA in a linear range of 0.5–1000 ng mL−1 with limit of detection (LOD) of 0.01 ng mL−1, which exhibits a great potential in clinical and cancer diagnostic applications. Here, CEACAM5 is linked to cancer.